Theratechnologies Inc. provided earnings guidance for the year 2024. For the year, the company expects revenue to be in the range of $87 million to $90 million, or growth of the commercial portfolio in the range of 6.4% to 10.0%, as compared to the 2023 fiscal year results.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.11 CAD | +7.11% |
|
+11.05% | -1.40% |
07-10 | Theratechnologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2024 | CI |
07-10 | Transcript : Theratechnologies Inc., Q2 2024 Earnings Call, Jul 10, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.40% | 71M | |
+7.40% | 101B | |
+7.76% | 42.18B | |
-14.37% | 32.26B | |
+80.61% | 29.79B | |
-12.27% | 16.06B | |
+2.33% | 14.45B | |
-8.56% | 12.01B | |
+182.74% | 10.71B | |
+4.57% | 8.89B |
- Stock Market
- Equities
- TH Stock
- News Theratechnologies Inc.
- Theratechnologies Inc. Provides Earnings Guidance for the Year 2024